Resmetirom is a safe medication with good tolerability in regard to the side effect profile for the first 3 months. Most patients were able to gain insurance approval but delays in dispensing and insurance requirements of invasive fibrosis testing to obtain approval were observed.

BACKGROUND Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder characterized by bilateral stenosis or occlusion of the internal carotid arteries and the development of fragile collateral vessels within the circle of Willis. The disease primarily affects the intracranial vasculature, with extracranial manifestations being exceedingly uncommon. Gastrointestinal (GI) involvement, in particular, is rarely described in the literature. CASE REPORT We present the case of a 20-year-old White man with a …

<title>Abstract</title> Background Emphysematous gastritis (EG) is a rare but life-threatening condition caused by gas-forming bacterial infection of the gastric wall. Despite increasing recognition, there are no standardized guidelines, leading to variability in diagnosis, management, and outcomes. This systematic review synthesizes current evidence on EG, focusing on epidemiology, clinical presentation, diagnostic modalities, treatment strategies, and prognostic factors. Methods A systematic literature search wa…

Abstract Background Childhood obesity is associated with a variety of complications that see their light throughout adulthood. Due to the serious side effects of these morbidities, early intervention is essential. Laparoscopic sleeve gastrectomy (SG) is a safe and effective procedure for the treatment of obesity, however, the long-term data on its use in adolescents is lacking in the literature. Methods A retrospective analysis was conducted on all patients that underwent SG aged between 12–21 years old at a publi…

Background and aims Patients infected with the SARS-CoV-2 usually report fever and respiratory symptoms. However, multiple gastrointestinal (GI) manifestations such as diarrhoea and abdominal pain have been described. The aim of this study was to evaluate the prevalence of GI symptoms, elevated liver enzymes and mortality of patients with COVID-19. Methods A systematic review and meta-analysis of published studies that included a cohort of patients infected with SARS-CoV-2 were performed from 1 December 2019 to 15…